Lawyers Zeynep Çağla Üstün

Zeynep Çağla Üstün

Zeynep Çağla Üstün

Gün + Partners

Practice Areas & Work Department

Intellectual Property

Patent and Utility Models

Life Sciences

Trademarks and Designs


Languages

English

Turkish


Memberships

Ankara Bar Association

Ankara Bar Association FMR Law Board

Artificial Intelligence and Pharmaceutical Industry: The Transformation in the Technology and Patent System Shaping the Future

Artificial intelligence influences every aspect of our lives and creates revolutionary effects in the pharmaceutical industry as well as in many other sectors.

02.12.2025

An Important European Precedent: Legal consequences of statements concerning competitors and its implications for Türkiye

In today’s business world, competition among companies is shaped not only by the quality of their products and services, but also by their communication strategies with the public.

24.07.2025

Birleşik Patent Mahkemesi’nin “Uzun Kolu” Türkiye’ye Uzanır Mı?

Birleşik Patent Mahkemesi'ni kuran Anlaşma yıllar süren çaba sonucunda 2013 yılında Avrupa Birliği üyesi devletlerin çoğunluğu tarafından imzalandı ve 1 Haziran 2023’de yürürlüğe girdi.

27.01.2025

Does the ‘Long Arm’ of the UPC Reach Turkey?

Selin Sinem Erciyas and Zeynep Çağla Üstün explore whether Turkey, as a non-EU state party to the European Patent Convention, might still face the Unified Patent Court’s jurisdiction under EU regulations.

21.01.2025

Yapay Zeka ve İlaç Endüstrisi: Geleceği Şekillendiren Teknoloji ve Patent Sistemindeki Dönüşüm

Yapay zeka, hayatımızın her alanına etki ederek pek çok sektörde olduğu gibi ilaç endüstrisinde de devrimsel etkiler yaratmaktadır.

27.11.2024

Artificial Intelligence and Pharmaceutical Industry: The Transformation in the Technology and Patent System Shaping the Future

Artificial intelligence influences every aspect of our lives and creates revolutionary effects in the pharmaceutical industry as well as in many other sectors. From DeepMind's AlphaGo success to Tempus' personalized approaches to cancer treatment, AI-enabled innovations offer ...

25.11.2024

Biyobenzer İlaçlar ve Patent Tecavüzü Karinesi

Jeneriklere karşı patent haklarının ileri sürülmesi için açılabilecek davaların öncesinde patent hakkı sahibi esasen karanlıkta ilerler. Çünkü özellikle jenerik ilacın kısa ürün bilgisinin henüz yayınlanmadığı veya patentin ihlal edilip edilmediğinin kısa ürün bilgisinde yer alan sınırlı bilgilerle anlaşılamadığı durumlarda ...

22.10.2024

Applying Presumption of Patent Infingement Against Biosimilars

Before filing lawsuits to assert patent rights against generics or biosimilars, the patent holder essentially operates in the dark.

24.09.2024
Load More
Ready to stay ahead of the curve?
Share your interest anonymously and let us guide you through the informative articles on the hottest legal topics.
|
Successful Your message has been sent